In Plattform Life Sciences, a German life sciences journal, Anton Dolgikh, Head of AI at DataArt, discusses the role of artificial intelligence in clinical trials, namely its significant impact on targets search, hits/leads search, adverse effects reduction, and old drugs repositioning.
Cliff Moyce, Head of the Finance Practice at DataArt, contributes a bylined article to C Suite, where he outlines five reasons not to fear artificial intelligence (AI).
In Health IT Outcomes, Alexander Myskiw, Engagement Manager in the Healthcare and Life Sciences Practice at DataArt, explores the advent of tech giants, including Amazon, Apple and Google, into the healthcare sector, and the future industry dynamics.
In ITProPortal, Rafael Zubairov, Senior Architect at DataArt, explains how a business can start using machine learning without dedicated software engineers or data science experts, and reviews the tools that make it possible.
In Goingpublic.de, a German finance journal, Cliff Moyce, Finance Practice Leader at DataArt, discusses various threats to cybersecurity, their impact on banks’ reputation and strategies for counteracting them.
IoT Now picks up the announcement of DataArt’s partnership with Espressif, a provider of ESP8266 and ESP32 chips that are used to add internet connectivity to devices. DataArt developed a custom DeviceHive firmware for Espressif’s ESP8266 chips that enables zero-configuration networking, supports a wide range of popular sensor devices and ensures direct connection with DeviceHive cloud service.
Charlotte Lamp Davies, VP of Travel & Hospitality Practice at DataArt Europe, talks to Travolution about the movement of locals to prevent ‘overtourism’ in a variety of destinations and shares her thoughts on how technology can be used to help alleviate the problem.
Technology Networks covers the announcement of DataArt joining BIO Deutschland, Germany's biotechnology industry association.